Navigation Links
Surprising Cystic Fibrosis Finding That Could Be A Helpful Treatment Option

Cystic fibrosis is a genetic disease where the patient has frequent respiratory infections, breathing difficulties and eventually permanent lung damage. // It’s believed that patients with CF have too much mucus in their airways. But new research shows patients actually have too little mucus.

Researchers say that may studies have been done in the past , but it has never proven, that CF causes the body to produce too much abnormally thick mucus that accumulates in the lungs and intestines . However recent studies have shown that these patients actually have very little mucus in their airways.

For the study, researchers collected sputum from 12 patients with CF and 11 patients without lung disease. Sputum is the mucus that is coughed up when someone has a deep cough. After analyzing the sputum, researchers found the CF patients had less than the healthy participants. Researchers say the substance that clogs the lungs of CF patients is actually pus. They suspect the airways in CF patients are chronically infected and fill up with pus. They think that by adding mucus, it could reduce the infection and the amount of pus.

Specialists say that if further studies prove that mucus is protective against the bacteria, they might have a new treatment option for CF which would make a wonderful difference in quality of life of the patient.

Page: 1

Related medicine news :

1. Blood Pressure Levels Across The Globe Show Surprising Drop
2. Surprising Interaction Between Genes, Gender, and Hypertension
3. Tamoxifen Discontinuation Rates Surprisingly High
4. Increases in Autism Rates Not Surprising to Education Expert
5. Gene Therapy For Cystic Fibrosis
6. The Use Of Colistin To Treat Cystic Fibrosis Questioned
7. Cystic fibrosis patients may require a new treatment for bacterial infection
8. Treatment for Cystic Fibrosis in the future
9. New Therapy Discovered By Scientists For Cystic Fibrosis
10. Inhaling Concentrated Saline Could Benefit Cystic Fibrosis Patients
11. New Multi-functional Sensing Tool To Investigate Cystic Fibrosis
Post Your Comments:

(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, ... at Work award to iHire in recognition of their exemplary accomplishments in worksite health ... annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... Those ... deal with these feelings, many turn to unhealthy avenues, such as drug or alcohol ... of Marne, Michigan, has released tools for healthy coping following a traumatic event. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Research and Markets has ... Global Analysis (United States, China, Japan, Brazil, United Kingdom, ... their offering. Surgical ... business planners, provides surgical procedure volume data in a ... an in-depth analysis of growth drivers and inhibitors, including ...
(Date:6/23/2016)... -- The Biotechnology industry might still be ... opportunities to investors. assesses the recent performances of ... XON ), Vertex Pharmaceuticals Inc. (NASDAQ: ... ), and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN ... complimentary trade alerts at: ...
(Date:6/23/2016)... Leading BioSciences Inc., a clinical-stage biopharmaceutical ... from a breakdown of the mucosal barrier, today ... as chief executive officer. Mr. Doyle, a ... and board of directors, previously served as chief ... provide continued leadership and strategic direction to the ...
Breaking Medicine Technology: